Samir Jha

Samir Jha

Auto-generated profile, based on publicly available information

Samir Jha

Bassett Medical Center, Cooperstown, NY

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2018 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
PTPratikshya Thapa
Pratikshya Thapa
ATAshish Thapa
Ashish Thapa
NKNabina Khadka
Nabina Khadka
RBRuchi Bhattarai
Ruchi Bhattarai
SJSamir Jha
Samir Jha
BBBibhusan Basnet
Bibhusan Basnet
Social media has provided an online environment for patients to discuss regarding their health and seek medical information. The primary aim of our study was to analyze the quality of information shared on YouTube regarding attention deficit hyperactivity disorder (ADHD). More than half of the videos, 91 (57.23%) had duration of fewer than 5 min. Only 8 (5.03%) videos were rated as highly useful whereas 61 (38.36%) videos were misleading. Interestingly, there was a significant higher (1203.38 ± 395) likes in the misleading group of videos, compared to 162.13 ± 169.63 likes in the very useful group, P = 0.012. Only a small fraction of videos had very useful information on ADHD. There is a need for high-quality, evidence-based, educational videos on ADHD for patient education.

1 October 2019 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
HTHarshith S. Thyagaturu
Harshith S. Thyagaturu
SJSamir Jha
Samir Jha
DDDennis Demeria
Dennis Demeria
INTRODUCTION: Sumatriptan, a 5-HT1B/1D (5-hydroxytryptamine-1B/1D) receptor agonist is the first line medication currently available for migraine and cluster headaches. The drug acts by selectively constricting the intracranial blood vessels. Also, studies have shown that estrogen modifies the levels of MAO-A (Monoamine oxidase-A) in the body thereby decreasing the metabolism of sumatriptan. In the past few decades, there has been a handful of reported cases of coronary vasospasm, myocardial infarction and ischemic colitis associated with sumatriptan use. We report a 57-year-old female who developed ischemic colitis in the setting of usage of increasing doses of sumatriptan along with estrogen. CASE DESCRIPTION/METHODS: A 57-year-old woman with a history of migraine headache, fibromyalgia, hypertension, diet-controlled diabetes mellitus, diverticulitis presented to the emergency room with sudden onset of left sided abdominal pain and 5 episodes of Bright red blood per rectum for one day. Medications included sumatriptan, estradiol, enalapril, venlafaxine, aspirin, and atorvastatin. On examination, left lumbar and left iliac quadrants tenderness was noted. Negative for peritoneal signs. Labs showed WBC 19.6 [3.7–10.6 cells/ul], Hb 15 [11.5–15.5 cells/ul], glucose 106 [70–139 mg/dL], lactic acid 3.2 [0.5–2.2 mmol/L], ESR 18 [<=30 mm/hr], CRP 10.2 [0.3–1.0 mg/dL]. CT abdomen and pelvis revealed findings suggestive of colitis extending from the hepatic flexure to sigmoid colon. Of note, she was using increasing doses of sumatriptan [100 mg tabs, at least 3 to 4 times a day] in the past few weeks for increased frequency of migraine headaches. Endoscopic findings are suggestive of ischemic colitis versus the others. Pathology of the mucosal biopsy showed hallmarks of ischemic colitis. Sumatriptan and estrogen were discontinued. The patient was followed up for a few weeks to months. She reported remarkable improvement of symptoms without any recurrence. DISCUSSION: Sumatriptan is a commonly prescribed abortive medicine for migraine, while ischemic colitis is one of its rare side effects. We aim to emphasize the synergistic effect of increasing doses of sumatriptan along with estrogen in causing ischemic colitis. Physicians should consider the diagnosis of sumatriptan-induced ischemic colitis in patients taking increased doses of this medication with concurrent estrogen usage, who develop severe abdominal pain, hematochezia and potentially counsel patient on cautious use of 5HT1 receptor agonist.

13 November 2019 in Blood
Verified
Journal Article
Open access
PKPrakash Kharel
Prakash Kharel
KGKarthik Gnanapandithan
Karthik Gnanapandithan
RPRamesh Pandey
Ramesh Pandey
SJSamir Jha
Samir Jha
AGAlyssa Grimshaw
Alyssa Grimshaw
SGSmith Giri
Smith Giri
Copper Deficiency and Cytopenia: A Systematic Review Prakash Kharel, Karthik Gnanapandithan, Ramesh Kumar Pandey, Samir Jha, Alyssa Grimshaw, Smith Giri Introduction: Copper deficiency is rare in humans unless there is a condition that affects either copper uptake or metabolism, or dietary deficiency. However, the incidence appears to be rising due to increasing gastric bypass surgery and total parenteral nutrition (TPN) use. Published data on hematological manifestations due to copper deficiency are limited to case reports, case series and small retrospective studies, creating confusion among clinicians and hematologists. We performed a systematic review of all published case reports and series to characterize hematological manifestations associated copper deficiency with a focus on risk factors, clinical manifestations, treatments and outcomes. Methods: Using a combination of free text and controlled vocabulary, a systematic search of the electronic literature using MEDLINE and EMBASE for published material from inception to March 2019 was performed. Two authors independently screened the titles, abstracts, and the full text of the selected papers. Subsequently, the full text of each article was assessed for eligibility and details. From the 97 reports, we included 116 cases in which the clinical course, management and outcomes were described. Results: Of 5374 articles screened, a total of 268 articles were selected for full text review and a total of 97 reports describing 116 cases met our eligibility criteria. The median age at the time of presentation was 44 (interquartile range (IQR) 25-57) year, and 64 (55%) were males. Total of 37(32 %) had coexisting neurological symptoms. The median Hb was 7.7 gm/dl (IQR 6.2-9.5) and median WBC 2.3 (1.6-3.1). 94 (81%) of the patients had hemoglobin (Hb)< 10, 41(35%) had severe anemia Hb <7 at presentation. 80(69%) had leukopenia with white blood cell (WBC) <4K, of them only one patient had lymphopenia (1.28%), rest had neutropenia (98.72 %). Nearly half of these patients had macrocytic anemia (38, 55%) and only 3 cases had microcytic anemia. Of 78 patients with available data, 23(29%) had low platelet counts and 8 (10 %) had elevated platelet count. Zinc excess was implicated in almost half of these cases (39/87, 45%) and total parenteral nutrition (TPN) in 9 out of 87 cases (10%) Conclusion: Copper deficiency should be one of the reflexes in evaluation of patient who is at risk of copper deficiency specially as there is rise of bariatric surgery, survivors of significant bowel surgery patient requiring total parenteral nutrition or jejunal feed along with the baby boomers who will be the high number of patients using dentures and patient on zinc supplementation. There should always be a high degree of suspicion among clinicians when dealing with at-risk individuals to prevent irreversible complications and morbidity.

16 November 2016 in Acta Oncologica
Verified
Journal Article
Open access
BSBinay Kumar Shah
Binay Kumar Shah
TRTaufiq Rajwani
Taufiq Rajwani
SJSamir Jha
Samir Jha
RFRyan R. Fortna
Ryan R. Fortna
(2017). Chronic lymphocytic leukemia presenting with hematuria. Acta Oncologica: Vol. 56, No. 1, pp. 113-115.

1 October 2019 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
SJSamir Jha
Samir Jha
HTHarshith Thyagaturu
Harshith Thyagaturu
NANurlan Aliyev
Nurlan Aliyev
CHCharles Hyman
Charles Hyman
INTRODUCTION: Clostridium difficile is the most common cause of healthcare associated infectious diarrhea. Normally inhabiting in the colon, this organism was found in jejunal aspirates, suggesting that the small bowel may act as reservoir. However, review of current literature showed C. difficile enteritis cases have occurred only in the presence of underlying surgical manipulation (resection/partial or total colectomy) or inflammatory bowel disease. Our patient is unique in not having any of the above-mentioned risk or predisposing factor, nor did he have any sign or symptom exhibiting any bowel disease. CASE DESCRIPTION/METHODS: A 35-year-old Caucasian male, presented to the hospital with complaint of severe acute abdominal pain, started as dull aching pain, about a week ago, associated with nausea and two episodes of loose stools, back pain and generalized body aches. He had a history of splenectomy due to ruptured splenic artery aneurysm and an episode of diverticulitis treated with intravenous antibiotics, 8 months ago. On the exam, he was found to have temperature of 38.1 deg. C with tachycardia and tachypnea. There was some tenderness to palpation over the epigastric region without any rebound tenderness. A white blood cell count showed leukocytosis of 34,000 cells/mm3. Intravenous Vancomycin and Piperacillin-Tazobactam were empirically started. A CT scan with intravenous contrast (without oral contrast) showed prominence of contiguous length of proximal and mid-jejunum in the left abdomen with concern for inflammation. Stool culture for Salmonella, Shigella, and Campylobacter was unremarkable, and Shiga toxin was negative. Two sets of blood culture obtained 15 minutes apart, didn’t grow any bacteria. Stool evaluation sent for C. difficile toxin Nucleic acid amplification Test (NAAT) was positive. He never had a C. difficile infection in the past. The intravenous antibiotics were discontinued and started on oral Vancomycin for 10 days. He significantly improved with the treatment; symptoms subsided and was discharged home. DISCUSSION: C. difficile, commonest cause for diarrhea in healthcare, can involve the small intestine, more so in surgically manipulated bowel or patients with IBD. As small bowel involvement is associated with a higher mortality than colonic involvement, it should be considered as a differential diagnosis for a patient presenting with enteritis, more so in patient with risk factors.